SANOFI group: subsidiaries and structure
Société anonyme (SA) · PARIS, France · LEI 549300E9PC51EN656011
76subsidiaries
33countries
37held directly
46lapsed LEIs
60links on accounts older than 24 months
5ISINs of subsidiaries
Summary
SANOFI is the ultimate parent of 76 subsidiaries with LEIs in 33 countries, as reported to GLEIF. 37 are held directly; the others sit below intermediate companies. The largest numbers are in the United Kingdom (8), in Ireland (6) and in Belgium (5). 46 of the subsidiaries have a lapsed LEI, and 60 links rest on accounts older than 24 months. GLEIF's ISIN mapping lists 931 ISINs for the parent and 5 ISINs for its subsidiaries.
Written from GLEIF data using fixed, reviewed sentence templates.
Subsidiaries by country
and 18 more
Data-quality notes (AssetCensus analysis)
No group-level data-quality notes in this data release.
60 subsidiaries have data-quality notes; they are listed on each company page.
Group structure
Indentation shows the direct parent reported to GLEIF.
SANOFI-AVENTIS ARGENTINA S. A. Argentina
OPELLA HEALTHCARE AUSTRIA GMBH Austria
ABLYNX Belgium
GENZYME FLANDERS Belgium
OPELLA HEALTHCARE BELGIUM NV/SA Belgium
SANOFI BELGIUM Belgium
Sanofi-Aventis (Suisse) SA Switzerland
OPELLA HEALTHCARE CZECH S.R.O. Czechia
Hoechst GmbH Germany
Nattermann Verwaltungs GmbH Germany
Sanofi-Aventis Deutschland GmbH Germany
OPELLA HEALTHCARE GROUP SAS France
OPELLA HEALTHCARE UK LIMITED United Kingdom
SANOFI-AVENTIS MAGYARORSZÁG KERESKEDELMI ÉS SZOLGÁLTATÓ ZÁRTKÖRŰEN MŰKÖDŐ RÉSZVÉNYTÁRSASÁG Hungary lapsed
OPELLA HEALTHCARE HUNGARY KFT Hungary
SANOFI INDIA LIMITED India
Genzyme Global S.à r.l. Luxembourg
SANOFI B.V. Netherlands
OPELLA HEALTHCARE ROMANIA S.R.L. Romania
SANOFI-AVENTIS SINGAPORE PTE. LTD. Singapore
OPELLA HEALTHCARE SINGAPORE PTE. LTD. Singapore
OPELLA HEALTHCARE SLOVAKIA S.R.O. Slovakia
GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP United States lapsed direct parent not in this group view
Subsidiaries
| Company | Country | City | LEI | Accounts year | Notes |
|---|---|---|---|---|---|
| SANOFI-AVENTIS ARGENTINA S. A. | Argentina | MARTINEZ | 98450006CFA87C0PE351 | 2023 | > 24 months |
| OPELLA HEALTHCARE AUSTRIA GMBH | Austria | WIEN | 21380013ENZ3BNNVPK82 | 2022 | > 24 months |
| SANOFI-AVENTIS AUSTRALIA PTY LTD | Australia | Sydney | 549300QE5TL3OLVXAX64 | 2022 | lapsed > 24 months |
| SANOFI BANGLADESH LIMITED | Bangladesh | DHAKA | 54930046K6A8D4EOML59 | 2017 | lapsed > 24 months |
| ABLYNX | Belgium | GHENT | 549300ZL08QVVII6W560 | 2024 | |
| GENZYME FLANDERS | Belgium | GEEL | 54930084QWB4RNUMOP10 | 2022 | > 24 months |
| OPELLA HEALTHCARE BELGIUM NV/SA | Belgium | MACHELEN | 549300X5ILL7ANXFY377 | 2022 | > 24 months |
| SANOFI BELGIUM | Belgium | MACHELEN | 549300R1WE1M15K65C96 | 2024 | |
| SANOFI EUROPEAN TREASURY CENTER SA | Belgium | BRUSSELS | 549300O1V4CK6HCZHH75 | 2021 | lapsed > 24 months |
| Aventis Pasteur Limited Master Trust | Canada | Toronto | 5493000STP7YVWCGQA51 | 2016 | lapsed > 24 months |
| Sanofi Pasteur Limited | Canada | TORONTO | 549300EWCIVUW1WF4Y95 | 2017 | lapsed > 24 months |
| Sanofi-Aventis Canada Inc. | Canada | Laval | 549300E0EBQIKIGGJQ11 | 2016 | lapsed > 24 months |
| HELVEPHARM AG | Switzerland | FRAUENFELD | 549300TFVBTCM8BM1O45 | 2016 | lapsed > 24 months |
| OPELLA HEALTHCARE SWITZERLAND AG | Switzerland | RISCH-ROTKREUZ | 549300IR5SPKIAV4GT78 | 2021 | lapsed > 24 months |
| Sanofi-Aventis (Suisse) SA | Switzerland | Vernier | 5493005MMXWNL62PQP36 | 2025 | |
| SANOFI PASTEUR S.A. | Chile | SANTIAGO | 959800F4BJQHF8PT7981 | 2022 | lapsed > 24 months |
| OPELLA HEALTHCARE CZECH S.R.O. | Czechia | PRAGUE | 213800NKA1MLHMQJKO73 | 2022 | > 24 months |
| A. NATTERMANN & CIE. GESELLSCHAFT MIT BESCHRÄNKTER HAFTUNG | Germany | FRANKFURT AM MAIN | 549300E20VFE3X1YYC18 | 2022 | lapsed > 24 months |
| Hoechst GmbH | Germany | Frankfurt am Main | 549300JK4RENAM94P588 | 2025 | |
| Nattermann Verwaltungs GmbH | Germany | Frankfurt am Main | 21380048ARY28MMXGS32 | 2025 | |
| Sanofi-Aventis Deutschland GmbH | Germany | Frankfurt am Main | 5493000M08EL707Q0J03 | 2025 | |
| Sanofi A/S | Denmark | Copenhagen | 5493002VGQ9FX03WBL61 | 2023 | lapsed > 24 months |
| OPELLA HEALTHCARE SPAIN S.L. | Spain | BARCELONA | 213800ZNR4H1B43YMR40 | 2024 | |
| SANOFI AVENTIS SA | Spain | BARCELONA | 549300YWWD2OLH6LGU05 | 2019 | lapsed > 24 months |
| OPELLA HEALTHCARE GROUP SAS | France | NEUILLY SUR SEINE | 213800I8BTSW6ITP9581 | 2024 | |
| OPELLA HEALTHCARE INTERNATIONAL SAS | France | NEUILLY SUR SEINE | 213800CHXBEF7JWVOM96 | 2024 | |
| SANOFI AVENTIS PARTICIPATIONS | France | GENTILLY | 969500P2JOO45JIIVY36 | 2023 | > 24 months |
| SANOFI PASTEUR NVL | France | NEUVILLE-SUR-SAÔNE | 969500F0PC7DK3NCLY80 | 2018 | lapsed > 24 months |
| AVENTIS PHARMA LIMITED | United Kingdom | GUILDFORD | 549300FHMPUBGQQXOZ27 | 2017 | lapsed > 24 months |
| FISONS LIMITED | United Kingdom | GUILDFORD | 549300BO0384X406MR24 | 2016 | lapsed > 24 months |
| GENZYME LIMITED | United Kingdom | HAVERHILL | 5493000L524MHZVTDH08 | 2017 | lapsed > 24 months |
| GENZYME THERAPEUTICS LIMITED | United Kingdom | OXFORD | 54930070ZX7ZM2WSJU92 | 2017 | lapsed > 24 months |
| MAY & BAKER LIMITED | United Kingdom | GUILDFORD | 549300EV4SSYXYXPFX38 | 2016 | lapsed > 24 months |
| OPELLA HEALTHCARE UK LIMITED | United Kingdom | READING | 21380058B61EN29UJP45 | 2023 | > 24 months |
| SANOFI-AVENTIS PENSIONS TRUST LIMITED | United Kingdom | GUILDFORD | 549300M2Y35NR2BYHT29 | 2018 | lapsed > 24 months |
| SANOFI-AVENTIS UK HOLDINGS LIMITED | United Kingdom | GUILDFORD | 549300H4ZG7JIH8FZJ30 | 2016 | lapsed > 24 months |
| OPELLA HEALTHCARE GREECE Ε.Π.Ε. | Greece | KALLITHEA | 213800158UFG4RQBNU49 | 2023 | > 24 months |
| RHONE-POULENC RORER ASIA PACIFIC LIMITED | Hong Kong | Hong Kong | 549300QF25WJC0QIBK49 | 2018 | lapsed > 24 months |
| Sanofi-Aventis Hong Kong Limited | Hong Kong | Hong Kong | 549300I4XRRG96APUI20 | 2019 | lapsed > 24 months |
| CHINOIN GYÓGYSZER-ÉS VEGYÉSZETI TERMÉKEK GYÁRA ZÁRTKÖRŰEN MŰKÖDŐ RT. | Hungary | BUDAPEST | 54930074B7OATBFFBM38 | 2021 | lapsed > 24 months |
| OPELLA HEALTHCARE COMMERCIAL KORLÁTOLT FELELŐSSÉGŰ TÁRSASÁG | Hungary | BUDAPEST | 213800O576FITQFKJI05 | 2022 | > 24 months |
| OPELLA HEALTHCARE HUNGARY KFT | Hungary | VERESEGYHÁZ | 2138008NU5V9SZRVSD62 | 2024 | |
| SANOFI-AVENTIS MAGYARORSZÁG KERESKEDELMI ÉS SZOLGÁLTATÓ ZÁRTKÖRŰEN MŰKÖDŐ RÉSZVÉNYTÁRSASÁG | Hungary | BUDAPEST | 549300XYOY44VF858H27 | 2021 | lapsed > 24 months |
| Carraig Insurance Designated Activity Company | Ireland | Dublin | 635400KISSIRFDGIGX71 | 2022 | > 24 months |
| CHATTEM GLOBAL CONSUMER PRODUCTS LIMITED | Ireland | DUBLIN | 549300VWFGQS1V421A26 | 2016 | lapsed > 24 months |
| GENZYME IRELAND LIMITED | Ireland | WATERFORD | 549300HGLBMWL67V4T34 | 2017 | lapsed > 24 months |
| SANOFI FINANCE IRELAND LIMITED | Ireland | DUBLIN | 54930067CVHLL8MC2X48 | 2021 | lapsed > 24 months |
| SANOFI IRELAND 1 LIMITED | Ireland | DUBLIN | 5493000TYBTPC0I36N29 | 2021 | lapsed > 24 months |
| SANOFI-AVENTIS IRELAND LIMITED | Ireland | DUBLIN | 5493007C77QX6CKKXB88 | 2017 | lapsed > 24 months |
| SANOFI HEALTHCARE INDIA PRIVATE LIMITED | India | MUMBAI | 335800XC2IQZEJFS5L19 | 2022 | > 24 months |
| SANOFI INDIA LIMITED | India | MUMBAI | 335800VFWLEY5V6PYH80 | 2024 | |
| OPELLA HEALTHCARE ITALY S.R.L. | Italy | MILAN | 213800FRS7EC5TW8WN76 | 2024 | |
| SANOFI S.R.L. | Italy | MILAN | 549300RDPB8HMF2RAQ15 | 2020 | lapsed > 24 months |
| SANOFI K.K. | Japan | SHINJUKU KU | 549300ZFK7J534CZ3P76 | 2018 | lapsed > 24 months |
| Genzyme Global S.à r.l. | Luxembourg | Schuttrange | 549300E78NZCDT2NB838 | 2025 | |
| AZTECA VACUNAS SA DE CV | Mexico | Mexico City | 549300AI567Y7I2WU492 | 2016 | lapsed > 24 months |
| SANOFI PASTEUR SA DE CV | Mexico | Mexico City | 5493007BHWICJCIOFA32 | 2021 | lapsed > 24 months |
| Sanofi-Aventis de Mexico S.A de CV | Mexico | Mexico City | 549300QCTCWUXVEEM693 | 2017 | lapsed > 24 months |
| SANOFI-AVENTIS WINTHROP, S.A. DE C.V. | Mexico | Mexico City | 549300NXVF4RL4K4ZD81 | 2017 | lapsed > 24 months |
| Suministrador De Vacunas S.a. De C.v. | Mexico | Mexico City | 549300VB6WUR5Z0VNH05 | 2016 | lapsed > 24 months |
| SANOFI B.V. | Netherlands | AMSTERDAM | 549300IXIBIGWEEWNK29 | 2024 | |
| SANOFI-AVENTIS NORGE AS | Norway | LYSAKER | 549300CC2S7PYNKUEC07 | 2019 | lapsed > 24 months |
| SANOFI-AVENTIS NEW ZEALAND LIMITED | New Zealand | AUCKLAND | 549300IA1NI6PWMPAX20 | 2021 | lapsed > 24 months |
| SANOFI-AVENTIS DE PANAMA S.A. | Panama | Panama City | 549300600KLXU4YGVO95 | 2018 | lapsed > 24 months |
| OPELLA HEALTHCARE POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ | Poland | WARSAW | 213800RPPB44XEX7H455 | 2024 | |
| SANOFI-AVENTIS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ | Poland | WARSAW | 549300WJD7VAHVFZE977 | 2020 | lapsed > 24 months |
| OPELLA HEALTHCARE ROMANIA S.R.L. | Romania | BUCAREST | 213800FEMCQQGMKJ8I42 | 2023 | > 24 months |
| Sanofi AB | Sweden | Stockholm | 549300NWOMV80S05LX66 | 2017 | lapsed > 24 months |
| AVENTIS PHARMA MANUFACTURING PTE LTD | Singapore | SINGAPORE | 549300L5HEKFUHN0D153 | 2016 | lapsed > 24 months |
| OPELLA HEALTHCARE SINGAPORE PTE. LTD. | Singapore | SINGAPORE | 5493000FQFRV6ATBFX04 | 2022 | > 24 months |
| SANOFI-AVENTIS SINGAPORE PTE. LTD. | Singapore | SINGAPORE | 549300N8SDYDCB12Q796 | 2024 | |
| OPELLA HEALTHCARE SLOVAKIA S.R.O. | Slovakia | BRATISLAVA | 2138004TMHESFVFFD243 | 2022 | > 24 months |
| Bioverativ Therapeutics Inc. | United States | Boston | 549300FG1M08D5DJ1X84 | 2018 | lapsed > 24 months |
| GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP | United States | BOSTON | 549300EC9IWPQT4CU957 | 2018 | lapsed > 24 months |
| Immunization Management Services Inc | United States | Scranton | 549300HEH2BDV1CFK175 | 2016 | lapsed > 24 months |
| Life Science Holdings Inc. | United States | Swiftwater | 549300ZFLOKM34NPIX29 | 2016 | lapsed > 24 months |